                         SEQUENCE LISTING

<110>  Novo Nordisk A/S
 
<120>  COMPOUNDS FOR USE IN NASH

<130>  180129

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  29
<212>  PRT
<213>  Homo Sapiens


<220>
<221>  SITE
<222>  (2)..(2)
<223>  X2 is Aib

<400>  1

His Xaa Gln Gly Thr Phe Thr Ser Asp Leu Ser Lys Tyr Leu Glu Ser 
1               5                   10                  15      


Lys Arg Ala Arg Glu Phe Val Gln Trp Leu Leu Lys Thr 
            20                  25                  


<210>  2
<211>  29
<212>  PRT
<213>  Homo Sapiens


<220>
<221>  SITE
<222>  (2)..(2)
<223>  X2 is Acb

<400>  2

His Xaa Gln Gly Thr Phe Thr Ser Asp Leu Ser Lys Tyr Leu Asp Leu 
1               5                   10                  15      


Arg Arg Ala Arg Asp Phe Val Gln Trp Leu Leu Lys Thr 
            20                  25                  


